Related Experiment Video
Updated: Jul 18, 2026
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Advances in lung cancer surgery: the role of segmentectomy in early-stage management
Luca Bertolaccini1, Monica Casiraghi1,2, Clarissa Uslenghi1
1Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Introduction:
The evolving landscape of surgical interventions for early-stage non-small cell lung cancer (NSCLC) necessitates a reassessment of the traditional gold standard of lobectomy versus emerging sublobar resections, prompting this critical narrative review.
Areas Covered:
This review encompasses recent randomized controlled trials, notably JCOG0802/WJOG4607L and CALGB140503, comparing lobectomy and sublobar resections for early-stage NSCLC, focusing on tumor size and recurrence rates. It also discusses the importance of individualized decision-making, future research avenues, and technological advancements in lung cancer surgery.
Expert Opinion:
In this rapidly evolving field, sublobar resections emerge as a viable alternative to lobectomy for tumors smaller than 2 cm in early-stage NSCLC, necessitating precise patient selection and ongoing technological advancements to optimize outcomes.
